Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...

To achieve more energy-dense batteries that aren’t unsustainably expensive, faster battery development is needed, as well as ...

Authorization is based on results from the Phase 3 CARTITUDE-4 (MMY3002) study, which showed treatment with CARVYKTI® reduced the risk of disease progression or death by 74 per cent compared to ...

The world's thinnest spaghetti, about 200 times thinner than a human hair, has been created by a UCL-led research team. The ...

The ability of non-brain cells to learn and form memories is a riveting discovery. This thought-provoking study provides us with a new understanding of memory’s mechanisms and paves the way for ...

Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose . SAN JOSE, Calif., Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" ...

killing the cell by shredding its DNA. (Orano Med/YouTube) This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on ...

Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial and operational ...

Trump has already made headway in tossing up potential cabinet members, making preparations for his second term after just one week since securing an historic election victory. As it stands ...

It hasn't even been a week since Donald Trump was declared the winner of the 2024 presidential election, and investors have high hopes for the president-elect's second term in the White House.